Penn Capital Management Company, LLC
Position in TGTX — Tg Therapeutics, Inc.
CIK 1158202
PHILADELPHIA, PA
Position in TGTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$18,003,911
+$1,962,644 QoQ
Shares Held
541,960
+0.7% QoQ
Ownership
0.354%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Penn Capital Management Company, LLC holds $79,843,281 across 7 Biotechnology names. TGTX ranks #3 (22.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
256,767 | $23,720,135 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
95,456 | $19,057,790 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
This page
|
541,960 | $18,003,911 | |
| 4 | SLNO |
Soleno Therapeutics Inc
|
268,785 | $8,998,921 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
333,130 | $7,848,542 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,510 | $1,837,379 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
12,676 | $376,603 |
All Filings in TGTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,003,911 | 541,960 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $16,041,267 | 538,117 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $18,830,517 | 521,260 | Shares | Sole | 2025-11-24 | |
| 2025-06-30 | $15,956,706 | 443,365 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,463,736 | 392,182 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,577,380 | 351,408 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||